1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow C4 Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma Cemsidomide, Dexamethasone - Multiple Myeloma, Relapsed/Refractory Multiple Myeloma | Phase 2 | Recruiting | C4 Therapeutics, Inc. | 100 | 2026-02-18 | 2026-08-06 |
Multiple Myeloma (1)
Dexamethasone (1)
United Kingdom (1) · United States (1)
Aurore Perrot, M.D. (1) · Binod Dhakal, M.D. (1) · Martin Kaiser, M.D. (1)